Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. - Hantel A; Luskin MR; Khan I; Warner E; Patel AA; Walsh TP; DeAngelo DJ; Lathan CS; Abel GA (Haematologica, 2024)